{
    "Trade/Device Name(s)": [
        "xTAG Cystic Fibrosis 60 kit v2"
    ],
    "Submitter Information": "Luminex Molecular Diagnostics Inc.",
    "510(k) Number": "k083845",
    "Predicate Device Reference 510(k) Number(s)": [
        "k043011",
        "k060627"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NUA"
    ],
    "Summary Letter Date": "December 11, 2009",
    "Summary Letter Received Date": "December 9, 2009",
    "Submission Date": "December 8, 2009",
    "Regulation Number(s)": [
        "21 CFR 866.5900"
    ],
    "Regulation Name(s)": [
        "CFTR (cystic fibrosis transmembrane conductance regulator) gene mutation detection system"
    ],
    "Analyte Class(es)": [
        "genetic molecular"
    ],
    "Analyte(s)": [
        "CFTR gene mutations and variants"
    ],
    "Specimen Type(s)": [
        "Peripheral human whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Luminex 100",
        "Luminex 200"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex PCR",
        "Multiplex allele specific primer extension",
        "Hybridization to fluorescent microparticles",
        "Detection by flow cytometry"
    ],
    "Methodologies": [
        "Genotyping",
        "Molecular diagnostic assay"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for xTAG Cystic Fibrosis 60 kit v2, a qualitative multiplex genetic test for CFTR gene mutations using the Luminex platform",
    "Indications for Use Summary": "Simultaneous qualitative detection and identification of a panel of CFTR gene mutations and variants in human blood, for carrier testing in adults of reproductive age, newborn screening aid, and confirmatory diagnostic testing in newborns and children (not for fetal/pre-implantation or stand-alone diagnostic use)",
    "fda_folder": "Immunology"
}